Wednesday, 20 November 2019

Generics News

  • Pharma FDI cap, right move for India

    Generics |  Opinion | By Nandita Singh | 0 Comment | 31 Jul, 2012

    India's pharma industry, mainly comprising generics has got a breather. The government in India has decided to cap brownfield foreign direct investment in pharma at 49 percent, allaying fea...Read more

  • GSK CEO: London HQ 'knew nothing' of the fraud

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Addressing the global media for the first time after allegations were leveled out against Britain's largest drugmaker, GlaxoSmithKline, the company's CEO Sir (Dr) Andrew Witty ha...Read more

  • FDA nod for Lupin's angina generic Ranolazine

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Mumbai: Lupin Phamaceuticals has received final approval for its Ranolazine extended-release tablets, 500 mg and 1000 mg from the US FDA. Lupin's Ranolazine extended-release tablets are th...Read more

  • Eli Lilly files $500 mn suit against Canada govt

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

    Singapore: Eli Lilly has filed a $500 million international lawsuit against the Canadian government alleging that the country's courts unfairly threw out these patents when challenged by ge...Read more

  • DRL launches Alchemia thrombosis generic in India

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2013

    Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic anti-coagulant product fondaparinux in India. This is the first time fo...Read more

  • Abbott Laboratories unveils strategy for India

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: Pharma major Abbott Laboratories has unveiled its strategy for the Indian market, claiming that it will push its best brands and focus on nutrition and over-the-counter drug port...Read more

  • Pfizer to acquire Innopharma at $360 mn

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2014

    Singapore: Global pharma firm, Pfizer, plans to acquire InnoPharma at approx $360 million to strengthen its generics, injectable and ophthalmic products. InnoPharma's current portfolio inc...Read more

  • Mylan launches operations in India with 18 ARV products

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2012

    Bangalore: Mylan Pharmaceuticals, a subsidiary of Mylan, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) produ...Read more

  • Mundipharma appoints John Lee as GM for SEA

    Generics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: Asian pharmaceutical firm, Mundipharma, has promoted the general manager of Mundipharma Korea, Mr John Lee, to the position of general manager for South Korea and South East Asia...Read more

  • Dr Reddy's launches Eszopiclone tablets in US

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2014

    Singapore: Dr Reddy's Laboratories has launched sedative drug, Eszopiclone tablets (C-IV) 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTA (eszopiclone) tablets C-IV...Read more

  • Bioscience firms queue up for Japan market

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into an aging society. A survey by the country's Ministry of Internal Affai...Read more

  • FDA clears 152 antiretroviral drugs for HIV/AIDS program

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: The US Food and Drug Administration (FDA) has approved or tentatively approved a total of 152 antiretroviral drugs in association with the President's Emergency Plan for AIDS Rel...Read more

  • Wockhardt gets FDA nod for generic treatment of enlarged prostate

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2012

    Mumbai: Pharmaceutical and biotechnology major Wockhardt has received final approval from the US Food & Drug Administration (US FDA) for marketing 10mg extended release tablets of Alfuz...Read more

  • RPG issued warning letter by US FDA

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2013

    Singapore: In what has come as another shocker for the Indian Pharmaceutical industry, the US FDA slammed RPG Life Sciences with a warning letter. The US FDA is said to have found two manu...Read more

  • Dr. Reddy's rides on biosimilar product line

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    India-headquartered Dr Reddy's Laboratories is making a strong name in biosimilars business in India and in the world. In 2011, the company focused on introducing new biosimilars, reachin...Read more

  • Sun Pharma to acquire Ranbaxy

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Apr, 2014

    Singapore: India based generics firm Sun Pharmaceutical Industries has announced to acquire Ranbaxy Laboratories through an all-stock transaction. Under the deal, Ranbaxy shareholders will ...Read more

  • Dr. Reddy's launches generic of Boniva

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Bangalore: Dr. Reddy's Laboratories has launched Ibandronate sodium tablets (150 mg), a bioequivalent generic version of Boniva tablets in the US market, following the approval by the US Fo...Read more

  • Lupin acquires Mexican firm Laboratorios Grin

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Mar, 2014

    Singapore: Foraying into South American pharmaceutical market, India based Lupin Pharmaceutical has acquired Mexico firm Laboratorios Grin. Mexico is one of the fastest growing pharmaceutic...Read more